Colgate-Palmolive Company $CL Holdings Lifted by Boston Trust Walden Corp

Boston Trust Walden Corp increased its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 4.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 239,099 shares of the company’s stock after buying an additional 10,961 shares during the quarter. Boston Trust Walden Corp’s holdings in Colgate-Palmolive were worth $21,734,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Westend Capital Management LLC grew its holdings in shares of Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock valued at $25,000 after buying an additional 140 shares in the last quarter. Cornerstone Planning Group LLC grew its holdings in shares of Colgate-Palmolive by 1,913.3% during the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock valued at $28,000 after buying an additional 287 shares in the last quarter. Saudi Central Bank purchased a new position in shares of Colgate-Palmolive during the first quarter valued at $29,000. Ransom Advisory Ltd acquired a new stake in Colgate-Palmolive during the first quarter valued at $33,000. Finally, Harel Insurance Investments & Financial Services Ltd. acquired a new stake in Colgate-Palmolive during the first quarter valued at $37,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $78.43 on Wednesday. Colgate-Palmolive Company has a fifty-two week low of $76.68 and a fifty-two week high of $102.61. The business has a 50-day moving average of $82.34 and a two-hundred day moving average of $87.67. The stock has a market capitalization of $63.39 billion, a P/E ratio of 22.03, a P/E/G ratio of 4.24 and a beta of 0.34. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. During the same quarter in the previous year, the firm earned $0.91 earnings per share. The business’s quarterly revenue was up 1.0% compared to the same quarter last year. On average, equities research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive’s payout ratio is currently 58.43%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on CL. Piper Sandler began coverage on Colgate-Palmolive in a research report on Friday, October 3rd. They set a “neutral” rating and a $84.00 price objective for the company. JPMorgan Chase & Co. reduced their price objective on Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating for the company in a research report on Friday, October 10th. Bank of America reduced their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Barclays reduced their price objective on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. Finally, Morgan Stanley reduced their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $92.21.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.